Skip to main content
Infection and Immunity logoLink to Infection and Immunity
. 1996 Oct;64(10):4163–4171. doi: 10.1128/iai.64.10.4163-4171.1996

Cloning, expression, and molecular characterization of the dermonecrotic toxin gene of Bordetella spp.

G D Pullinger 1, T E Adams 1, P B Mullan 1, T I Garrod 1, A J Lax 1
PMCID: PMC174352  PMID: 8926084

Abstract

A cosmid library of random fragments of Bordetella bronchiseptica genomic DNA was prepared and screened with oligonucleotides designed from the sequence of the B. pertussis dermonecrotic toxin (DNT) gene. Two cosmid clones which apparently contained the complete B. bronchiseptica DNT gene were identified, but they did not express the toxin. A 5-kb fragment containing the DNT gene was subcloned from one of the cosmid clones onto a high-copy-number plasmid, and this resulted in low-level expression of the toxin. The expression level was increased by deletion of a small region upstream of the coding sequence. Assays for biological activity, including the infant mouse dermonecrosis assay, confirmed that the product of the cloned gene was DNT. The complete sequence of the B. bronchiseptica DNT gene was determined and was more than 99% homologous to the DNT gene of B. pertussis. A putative purine nucleotide-binding motif was shown to be important for toxic activity. Extracts containing the recombinant or the native toxin induced DNA synthesis in Swiss 3T3 cells but inhibited cell division leading to binucleation.

Full Text

The Full Text of this article is available as a PDF (537.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aricò B., Rappuoli R. Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol. 1987 Jun;169(6):2847–2853. doi: 10.1128/jb.169.6.2847-2853.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Aricó B., Miller J. F., Roy C., Stibitz S., Monack D., Falkow S., Gross R., Rappuoli R. Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc Natl Acad Sci U S A. 1989 Sep;86(17):6671–6675. doi: 10.1073/pnas.86.17.6671. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brosius J., Holy A. Regulation of ribosomal RNA promoters with a synthetic lac operator. Proc Natl Acad Sci U S A. 1984 Nov;81(22):6929–6933. doi: 10.1073/pnas.81.22.6929. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Caprioli A., Falbo V., Roda L. G., Ruggeri F. M., Zona C. Partial purification and characterization of an escherichia coli toxic factor that induces morphological cell alterations. Infect Immun. 1983 Mar;39(3):1300–1306. doi: 10.1128/iai.39.3.1300-1306.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cowell J. L., Hewlett E. L., Manclark C. R. Intracellular localization of the dermonecrotic toxin of Bordetella pertussis. Infect Immun. 1979 Sep;25(3):896–901. doi: 10.1128/iai.25.3.896-901.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Dever T. E., Glynias M. J., Merrick W. C. GTP-binding domain: three consensus sequence elements with distinct spacing. Proc Natl Acad Sci U S A. 1987 Apr;84(7):1814–1818. doi: 10.1073/pnas.84.7.1814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Dicker P., Rozengurt E. Phorbol esters and vasopressin stimulate DNA synthesis by a common mechanism. Nature. 1980 Oct 16;287(5783):607–612. doi: 10.1038/287607a0. [DOI] [PubMed] [Google Scholar]
  8. Endoh M., Amitani M., Nakase Y. Purification and characterization of heat-labile toxin from Bordetella bronchiseptica. Microbiol Immunol. 1986;30(7):659–673. doi: 10.1111/j.1348-0421.1986.tb02992.x. [DOI] [PubMed] [Google Scholar]
  9. Falbo V., Pace T., Picci L., Pizzi E., Caprioli A. Isolation and nucleotide sequence of the gene encoding cytotoxic necrotizing factor 1 of Escherichia coli. Infect Immun. 1993 Nov;61(11):4909–4914. doi: 10.1128/iai.61.11.4909-4914.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fiorentini C., Arancia G., Caprioli A., Falbo V., Ruggeri F. M., Donelli G. Cytoskeletal changes induced in HEp-2 cells by the cytotoxic necrotizing factor of Escherichia coli. Toxicon. 1988;26(11):1047–1056. doi: 10.1016/0041-0101(88)90203-6. [DOI] [PubMed] [Google Scholar]
  11. Goodnow R. A. Biology of Bordetella bronchiseptica. Microbiol Rev. 1980 Dec;44(4):722–738. doi: 10.1128/mr.44.4.722-738.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Grunstein M., Hogness D. S. Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A. 1975 Oct;72(10):3961–3965. doi: 10.1073/pnas.72.10.3961. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Horiguchi Y., Nakai T., Kume K. Effects of Bordetella bronchiseptica dermonecrotic toxin on the structure and function of osteoblastic clone MC3T3-e1 cells. Infect Immun. 1991 Mar;59(3):1112–1116. doi: 10.1128/iai.59.3.1112-1116.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Horiguchi Y., Nakai T., Kume K. Purification and characterization of Bordetella bronchiseptica dermonecrotic toxin. Microb Pathog. 1989 May;6(5):361–368. doi: 10.1016/0882-4010(89)90078-8. [DOI] [PubMed] [Google Scholar]
  15. Horiguchi Y., Nakai T., Kume K. Simplified procedure for purification of Bordetella bronchiseptica dermonecrotic toxin. FEMS Microbiol Lett. 1990 Jan 1;54(1-3):39–43. doi: 10.1016/0378-1097(90)90255-o. [DOI] [PubMed] [Google Scholar]
  16. Horiguchi Y., Senda T., Sugimoto N., Katahira J., Matsuda M. Bordetella bronchiseptica dermonecrotizing toxin stimulates assembly of actin stress fibers and focal adhesions by modifying the small GTP-binding protein rho. J Cell Sci. 1995 Oct;108(Pt 10):3243–3251. doi: 10.1242/jcs.108.10.3243. [DOI] [PubMed] [Google Scholar]
  17. Horiguchi Y., Sugimoto N., Matsuda M. Bordetella bronchiseptica dermonecrotizing toxin stimulates protein synthesis in an osteoblastic clone, MC3T3-E1 cells. FEMS Microbiol Lett. 1994 Jul 1;120(1-2):19–22. doi: 10.1111/j.1574-6968.1994.tb07001.x. [DOI] [PubMed] [Google Scholar]
  18. Horiguchi Y., Sugimoto N., Matsuda M. Stimulation of DNA synthesis in osteoblast-like MC3T3-E1 cells by Bordetella bronchiseptica dermonecrotic toxin. Infect Immun. 1993 Sep;61(9):3611–3615. doi: 10.1128/iai.61.9.3611-3615.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Iida T., Okonogi T. Lienotoxicity of Bordetella pertussis in mice. J Med Microbiol. 1971 Feb;4(1):51–61. doi: 10.1099/00222615-4-1-51. [DOI] [PubMed] [Google Scholar]
  20. Kume K., Nakai T., Samejima Y., Sugimoto C. Properties of dermonecrotic toxin prepared from sonic extracts Bordetella bronchiseptica. Infect Immun. 1986 May;52(2):370–377. doi: 10.1128/iai.52.2.370-377.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Lacerda H. M., Lax A. J., Rozengurt E. Pasteurella multocida toxin, a potent intracellularly acting mitogen, induces p125FAK and paxillin tyrosine phosphorylation, actin stress fiber formation, and focal contact assembly in Swiss 3T3 cells. J Biol Chem. 1996 Jan 5;271(1):439–445. doi: 10.1074/jbc.271.1.439. [DOI] [PubMed] [Google Scholar]
  22. Lax A. J., Chanter N., Pullinger G. D., Higgins T., Staddon J. M., Rozengurt E. Sequence analysis of the potent mitogenic toxin of Pasteurella multocida. FEBS Lett. 1990 Dec 17;277(1-2):59–64. doi: 10.1016/0014-5793(90)80809-w. [DOI] [PubMed] [Google Scholar]
  23. Lax A. J. Is phase variation in Bordetella caused by mutation and selection? J Gen Microbiol. 1985 Apr;131(4):913–917. doi: 10.1099/00221287-131-4-913. [DOI] [PubMed] [Google Scholar]
  24. Lax A. J., Pullinger G. D., Baird G. D., Williamson C. M. The virulence plasmid of Salmonella dublin: detailed restriction map and analysis by transposon mutagenesis. J Gen Microbiol. 1990 Jun;136(6):1117–1123. doi: 10.1099/00221287-136-6-1117. [DOI] [PubMed] [Google Scholar]
  25. Livey I., Wardlaw A. C. Production and properties of Bordetella pertussis heat-labile toxin. J Med Microbiol. 1984 Feb;17(1):91–103. doi: 10.1099/00222615-17-1-91. [DOI] [PubMed] [Google Scholar]
  26. Magyar T., Chanter N., Lax A. J., Rutter J. M., Hall G. A. The pathogenesis of turbinate atrophy in pigs caused by Bordetella bronchiseptica. Vet Microbiol. 1988 Oct;18(2):135–146. doi: 10.1016/0378-1135(88)90059-4. [DOI] [PubMed] [Google Scholar]
  27. Monack D. M., Arico B., Rappuoli R., Falkow S. Phase variants of Bordetella bronchiseptica arise by spontaneous deletions in the vir locus. Mol Microbiol. 1989 Dec;3(12):1719–1728. doi: 10.1111/j.1365-2958.1989.tb00157.x. [DOI] [PubMed] [Google Scholar]
  28. Oswald E., Sugai M., Labigne A., Wu H. C., Fiorentini C., Boquet P., O'Brien A. D. Cytotoxic necrotizing factor type 2 produced by virulent Escherichia coli modifies the small GTP-binding proteins Rho involved in assembly of actin stress fibers. Proc Natl Acad Sci U S A. 1994 Apr 26;91(9):3814–3818. doi: 10.1073/pnas.91.9.3814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Parton R., Hall E., Wardlaw A. C. Responses to Bordetella pertussis mutant strains and to vaccination in the coughing rat model of pertussis. J Med Microbiol. 1994 May;40(5):307–312. doi: 10.1099/00222615-40-5-307. [DOI] [PubMed] [Google Scholar]
  30. Roop R. M., 2nd, Veit H. P., Sinsky R. J., Veit S. P., Hewlett E. L., Kornegay E. T. Virulence factors of Bordetella bronchiseptica associated with the production of infectious atrophic rhinitis and pneumonia in experimentally infected neonatal swine. Infect Immun. 1987 Jan;55(1):217–222. doi: 10.1128/iai.55.1.217-222.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Roy C. R., Falkow S. Identification of Bordetella pertussis regulatory sequences required for transcriptional activation of the fhaB gene and autoregulation of the bvgAS operon. J Bacteriol. 1991 Apr;173(7):2385–2392. doi: 10.1128/jb.173.7.2385-2392.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Roy C. R., Miller J. F., Falkow S. The bvgA gene of Bordetella pertussis encodes a transcriptional activator required for coordinate regulation of several virulence genes. J Bacteriol. 1989 Nov;171(11):6338–6344. doi: 10.1128/jb.171.11.6338-6344.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Rozengurt E., Higgins T., Chanter N., Lax A. J., Staddon J. M. Pasteurella multocida toxin: potent mitogen for cultured fibroblasts. Proc Natl Acad Sci U S A. 1990 Jan;87(1):123–127. doi: 10.1073/pnas.87.1.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Rutter J. M., Luther P. D. Cell culture assay for toxigenic Pasteurella multocida from atrophic rhinitis of pigs. Vet Rec. 1984 Apr 21;114(16):393–396. doi: 10.1136/vr.114.16.393. [DOI] [PubMed] [Google Scholar]
  35. Saraste M., Sibbald P. R., Wittinghofer A. The P-loop--a common motif in ATP- and GTP-binding proteins. Trends Biochem Sci. 1990 Nov;15(11):430–434. doi: 10.1016/0968-0004(90)90281-f. [DOI] [PubMed] [Google Scholar]
  36. Stibitz S., Aaronson W., Monack D., Falkow S. Phase variation in Bordetella pertussis by frameshift mutation in a gene for a novel two-component system. Nature. 1989 Mar 16;338(6212):266–269. doi: 10.1038/338266a0. [DOI] [PubMed] [Google Scholar]
  37. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Walker K. E., Weiss A. A. Characterization of the dermonecrotic toxin in members of the genus Bordetella. Infect Immun. 1994 Sep;62(9):3817–3828. doi: 10.1128/iai.62.9.3817-3828.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Wardlaw A. C., Parton R., Hooker M. J. Loss of protective antigen, histamine-sensitising factor and envelope polypeptides in cultural variants of Bordetella pertussis. J Med Microbiol. 1976 Feb;9(1):89–100. doi: 10.1099/00222615-9-1-89. [DOI] [PubMed] [Google Scholar]
  40. Weiss A. A., Falkow S. Genetic analysis of phase change in Bordetella pertussis. Infect Immun. 1984 Jan;43(1):263–269. doi: 10.1128/iai.43.1.263-269.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Weiss A. A., Goodwin M. S. Lethal infection by Bordetella pertussis mutants in the infant mouse model. Infect Immun. 1989 Dec;57(12):3757–3764. doi: 10.1128/iai.57.12.3757-3764.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Weiss A. A., Hewlett E. L. Virulence factors of Bordetella pertussis. Annu Rev Microbiol. 1986;40:661–686. doi: 10.1146/annurev.mi.40.100186.003305. [DOI] [PubMed] [Google Scholar]
  43. Zhang Y. L., Sekura R. D. Purification and characterization of the heat-labile toxin of Bordetella pertussis. Infect Immun. 1991 Oct;59(10):3754–3759. doi: 10.1128/iai.59.10.3754-3759.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES